PRECISION BIOSCIENCES INC Deferred Revenue, Revenue Recognized
PRECISION BIOSCIENCES INC (DTIL) reported Deferred Revenue, Revenue Recognized of $5.10 million for the 6-month period ending 2019-06-30, per its 10-Q filed 2019-08-14.
Discontinued › Income Statement › Other Income
us-gaap:DeferredRevenueRevenueRecognized1 · last filed 2019-08-14
- PRECISION BIOSCIENCES INC deferred revenue, revenue recognized for the quarter ending 2019-03-31 was $4.00M.
| Period end | Deferred Revenue, Revenue Recognized 3 month | Deferred Revenue, Revenue Recognized 6 month |
|---|---|---|
| 2019-06-30 | $5.10M 10-Q · filed 2019-08-14 | |
| 2019-03-31 | $4.00M 10-Q · filed 2019-04-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |